NEW YORK (GenomeWeb) – Vela Diagnostics has received approval from the Singapore Health Sciences Authority for in vitro diagnostic use of its Sentosa SQ HIV Genotyping Assay.

The next generation sequencing-based panel also attained CE-IVD status and approval from the Therapeutic Goods Administration in Australia earlier this year.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.